ATOSSA THERAPEUTICS, INC. Quarterly Share-based Payment Arrangement, Expense in USD from Q1 2014 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Atossa Therapeutics, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q1 2014 to Q2 2024.
  • Atossa Therapeutics, Inc. Share-based Payment Arrangement, Expense for the quarter ending June 30, 2024 was $352K, a 78% decline year-over-year.
  • Atossa Therapeutics, Inc. Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2024 was $2.21M, a 65.3% decline year-over-year.
  • Atossa Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $4.62M, a 31.9% decline from 2022.
  • Atossa Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $6.79M, a 28.9% increase from 2021.
  • Atossa Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $5.27M, a 74.5% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $2.21M $352K -$1.25M -78% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-12
Q1 2024 $3.47M $417K -$1.16M -73.5% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-13
Q4 2023 $4.62M $519K -$1.03M -66.4% Oct 1, 2023 Dec 31, 2023 10-K 2024-04-01
Q3 2023 $5.65M $926K -$740K -44.4% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-13
Q2 2023 $6.39M $1.6M -$168K -9.49% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-12
Q1 2023 $6.56M $1.57M -$233K -12.9% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-13
Q4 2022 $6.79M $1.55M -$74K -4.57% Oct 1, 2022 Dec 31, 2022 10-K 2024-04-01
Q3 2022 $6.86M $1.67M -$128K -7.14% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 $6.99M $1.77M +$557K +45.9% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 $6.43M $1.81M +$1.17M +182% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 $5.27M $1.62M +$988K +157% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-22
Q3 2021 $4.28M $1.79M +$1.13M +170% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-07
Q2 2021 $3.15M $1.21M +$178K +17.1% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-08
Q1 2021 $2.97M $640K -$47.8K -6.94% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-09
Q4 2020 $3.02M $631K -$125K -16.5% Oct 1, 2020 Dec 31, 2020 10-K 2022-02-28
Q3 2020 $3.14M $664K -$88.1K -11.7% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 $3.23M $1.04M -$4.28M -80.5% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-13
Q1 2020 $7.51M $688K +$412K +149% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-14
Q4 2019 $7.1M $756K Oct 1, 2019 Dec 31, 2019 10-K 2021-03-31
Q3 2019 $752K +$420K +126% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-13
Q2 2019 $5.32M +$5.14M +2871% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-13
Q1 2019 $276K Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-13
Q3 2018 $332K +$108K +48.1% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-13
Q2 2018 $179K -$2.36K -1.3% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-13
Q4 2017 $787K $226K +$25.00 +0.01% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-28
Q3 2017 $787K $224K -$33.1K -12.9% Jul 1, 2017 Sep 30, 2017 10-Q 2017-11-13
Q2 2017 $820K $181K -$18.8K -9.38% Apr 1, 2017 Jun 30, 2017 10-Q 2017-08-14
Q1 2017 $838K $155K -$37.8K -19.6% Jan 1, 2017 Mar 31, 2017 10-Q 2017-05-11
Q4 2016 $876K $226K +$58K +34.5% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-08
Q3 2016 $818K $257K -$60.6K -19.1% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-13
Q2 2016 $879K $200K -$4.93K -2.4% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-14
Q1 2016 $884K $192K +$43.6K +29.3% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-11
Q4 2015 $840K $168K +$157K +1405% Oct 1, 2015 Dec 31, 2015 10-K/A 2017-03-21
Q3 2015 $683K $318K +$171K +116% Jul 1, 2015 Sep 30, 2015 10-Q/A 2017-03-21
Q2 2015 $513K $205K +$37.6K +22.4% Apr 1, 2015 Jun 30, 2015 10-Q/A 2017-03-21
Q1 2015 $475K $149K -$81.3K -35.3% Jan 1, 2015 Mar 31, 2015 10-Q/A 2017-03-21
Q4 2014 $556K $11.2K Oct 1, 2014 Dec 31, 2014 10-K 2016-03-30
Q3 2014 $147K Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-12
Q2 2014 $168K Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-06
Q1 2014 $230K Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.